Please provide your email address to receive an email when new articles are posted on . 56 microRNAs were upregulated and 64 were downregulated in hereditary angioedema. Two microRNAs were ...

Hereditary angioedema is a potentially life-threatening autosomal dominant condition, causing attacks of angioedema due to failure to regulate bradykinin. Nearly all cases of hereditary angioedema are ...

Thus, ACE inhibitors appear not to mediate angioedema through an allergic or idiosyncratic reaction; rather, they seem to facilitate angioedema in predisposed individuals. Despite the aforementioned ...

Hereditary angioedema (HAE) is a genetic condition featuring episodes of painful, rapid swelling under the skin. Stress is one of the most common triggers of HAE. Hereditary angioedema is an inherited ...

With the approval of the FDA, garadacimab can help patients with hereditary angioedema (HAE) prevent attacks by shutting down the contact pathway. Today, the FDA approved CSL’s garadacimab-gxii ...

Deucrictibant significantly improved the time to onset of symptom relief, defined as PGI-C of at least “a little better”, compared with placebo (1.28 vs >12 hours). Topline data were announced from a ...

Rapid swelling from hereditary angioedema can result from a variety of triggers. Doctors may use prophylactic medications to try and prevent these episodes, but managing stress and developing healthy ...

The pipeline of investigational therapies for hereditary angioedema (HAE) includes both novel inhibitors of known molecular targets and more ambitious gene editing-based approaches. Selected agents ...

The FDA has granted Fast Track designation to BW-20805, an investigational small interfering RNA therapy for hereditary angioedema.